The 1994 Waynberg clinical study, proposed mechanisms, and why Muira Puama works best as one layer in a multi-ingredient formula.
By Dr. Ethan Caldwell, MD · Published 2026-04-12 · Last Updated April 2026
Muira Puama — Portuguese for “potency wood” — is a small tree native to the Brazilian Amazon rainforest, with a traditional use history spanning indigenous medicine, Brazilian herbal practice, and European phytomedicine since the 1920s. The French clinical research from the early 1990s is what put Muira Puama on the map in modern male vitality supplementation, and understanding that research helps calibrate what the herb can realistically contribute.
Muira Puama (Ptychopetalum olacoides) grows in the Amazon basin and is traditionally prepared as a root decoction or alcohol tincture. Brazilian indigenous medicine uses it for neuromuscular fatigue, sexual weakness, and chronic stress — a use pattern broadly consistent with modern understanding of adaptogens. European herbalists adopted Muira Puama in the early 20th century, where it became part of traditional phytomedicine preparations for male sexual dysfunction.
The active constituents include alkaloids (including muirapuamine), sterols (beta-sitosterol, sitostenone, lupeol), coumarin derivatives, and essential oils. No single compound has been identified as the sole active fraction — Muira Puama's effects appear to derive from a synergistic combination, which is typical for adaptogenic herbs.
The most frequently cited Muira Puama research is a 1994 open-label clinical study by French physician Dr. Jacques Waynberg. In this study, 262 men presenting with “sexual asthenia” (lack of sexual drive) and “inability to attain or maintain erection” were given standardised Muira Puama extract for two weeks. The results, while open-label and without placebo control, reported that 62% of patients with lack of desire rated treatment as having a dynamic effect, and 51% with erectile function concerns reported significant improvement.
The Waynberg study is methodologically limited — open-label design, patient self-report, no placebo control — but the response rates are unusually high for botanical male vitality interventions and established Muira Puama as a legitimate supportive ingredient. Subsequent research has been more limited, with most contemporary use based on the Waynberg findings plus traditional use context.
The proposed mechanisms are multi-pathway rather than single-target. First, adaptogenic CNS support: the alkaloid and sterol fractions appear to support central nervous system function under stress, reducing the fatigue and mood components that can compound physical libido issues. This is consistent with traditional use for neuromuscular fatigue and chronic stress.
Second, circulatory support: some research suggests mild vascular effects that could support erectile function, though this mechanism is less well-characterised than for Ginkgo or Hawthorn. Third, testosterone-supportive activity: the sterol fraction may have mild hormonal effects, though this is less clearly established than for Tribulus or Epimedium.
The honest characterisation is that Muira Puama's mechanism is not as well-understood as its observed effects suggest. Traditional use and the Waynberg findings support inclusion as an active ingredient; mechanism research is still developing.
Muira Puama is rarely a standalone intervention in contemporary use — it's typically combined with other ingredients in male vitality formulas. This makes pharmacological sense. The apparent multi-pathway activity (CNS, circulatory, mild hormonal) complements ingredients with more single-target mechanisms. In VitalPro specifically, Muira Puama pairs with Damiana for the psychological/mood dimension, Epimedium and Tribulus for hormonal signalling, and Ginkgo plus Hawthorn for circulation.
This combination approach addresses the multi-dimensional nature of male drive concerns. Most men with age-related drive issues have both hormonal AND circulatory AND psychological components simultaneously. Single-ingredient interventions typically address only one dimension and miss the others.
VitalPro uses 200mg of Muira Puama root per serving. The Waynberg study used approximately 1,500mg daily of a tincture preparation, but contemporary capsule doses typically range from 100-500mg. VitalPro's 200mg sits in the middle range, appropriate for a multi-ingredient formula context.
Paired with Catuaba (84.5mg) — another Brazilian Amazonian aphrodisiac with similar CNS-supportive properties — Muira Puama contributes to what some Brazilian herbalists call the “Amazonian Vitality Duo.” This traditional pairing combines two complementary ingredients that work on overlapping pathways in the Amazonian herbal tradition.
Muira Puama has an excellent safety profile with minimal reported adverse effects in traditional or contemporary use. Rare reports include mild overstimulation or insomnia if dosed in the evening. No significant drug interactions have been documented. It is suitable for most adult men without prescription medications; those on antidepressants (especially MAOIs) should consult a physician before adding any CNS-active botanical.
Muira Puama is an evidence-plus-tradition ingredient with one notable open-label clinical study and a long traditional use history in Brazilian Amazonian medicine. It's not the most research-backed male vitality ingredient, but it contributes multi-pathway activity that complements better-characterised ingredients. In VitalPro's multi-ingredient formula, Muira Puama's 200mg inclusion is appropriate and adds a dimension that pure TCM or Ayurvedic formulations miss. Men seeking rigorously researched single-ingredient interventions will prefer Ginseng or Epimedium; men wanting comprehensive multi-tradition support benefit from formulas that include Muira Puama alongside those more heavily studied ingredients.
For the complete ingredient-by-ingredient analysis, pricing breakdown, and 10-FAQ accordion, see our main VitalPro review.
View Full VitalPro Review →